DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 1.28% to $945.53 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.23% to 7,323.63 and Dow Jones Industrial Average falling 1.11% to 50,198.17.
Regeneron Pharmaceuticals Inc. closed 4.66% short of its 52-week high of $991.73, which the company reached on November 4th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ fell 3.07% to $443.89, Moderna Inc. (MRNA) fell 4.84% to $196.79, and Gilead Sciences Inc. (GILD) fell 0.75% to $168.98.
Trading volume (703,274) remained 142,664 below its 50-day average volume of 845,938.
Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2026.
Comments